http://www.fpnotebook.com/
ZolpidemAka: Zolpidem CR, Ambien
- Indication
- Insomnia
- Sleep maintenance (CR version)
- Dose: Regular formulation
- Adult: 10 mg orally at bedtime
- Elderly: 2.5 to 5 mg orally at bedtime
- Dose: Controlled release (CR)
- Adult: 12.5 mg orally at bedtime
- Pharmacokinetics
- Peak onset: <30 minutes
- Duration: 4-8 hours (6-8 hours with CR version)
- Half-Life: 2-3 hours (longer with CR version)
- Metabolized by CYP450 3A4
- Mechanism
- Nonbenzodiazepine hypnotic agent
- Acts at omega 1 subtype Benzodiazepine receptor
- No anticonvulsant or myorelaxant effects
- Lactation
- Compatible with Breast Feeding per AAP
- Lack of longterm data - other medications are preferred
- Pregnancy
- Pregnancy Class B (not CR version)
- Lack of longterm data - other medications are preferred
- Drug Interactions
- Avoid taking with food or immediately after a meal
- Delays onset of action
- Decreases maximal concentration
- Avoid taking with Alcohol
- May increase CNS depression
- Adverse effects
- See Nonbenzodiazepine hypnotic agent for common effects
- Abdominal Pain or gastrointestinal upset
- Rebound Insomnia
- Nightmares
- Sleep-eating is more common
|
|---|
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | zolpidem, ZOLPIDEM PREPARATION, ZPD |
| Spanish | zolpidem |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
|
|---|
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | Ambien, Sanofi brand of zolpidem tartrate |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree